Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.54 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | DRD4 | P21917 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4246345 | 0.94 | PARP10 (0.64) | PARP10MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL4245174 | 0.92 | PARP10 (0.60) | PARP10MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL4244744 | 0.89 | PARP10 (0.53) | PARP10MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL4241028 | 0.89 | MEN1 (0.53) | PARP10MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL4251983 | 0.84 | PARP10 (0.62) | PARP10GAANPC1RAB9A | |
| SCHEMBL27670250 | 0.83 | PARP10 (0.61) | PARP10NPC1RAB9A | |
| SCHEMBL4239342 | 0.83 | SMN1; SMN2 (0.63) | MEN1KMT2ASMN1; SMN2GRIN1GRIN2B | |
| SCHEMBL4958207 | 0.82 | MEN1 (0.65) | MEN1KMT2ASMN1; SMN2GRIN1GRIN2B | |
| SCHEMBL27689205 | 0.82 | PARP10 (0.58) | PARP10NPC1RAB9A | |
| SCHEMBL4239619 | 0.81 | GAA (0.65) | MEN1KMT2AGAAGRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090170901-A1 | Benzoyl Urea Derivatives | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170901-A1 | Benzoyl Urea Derivatives | OPRM1, GRIN2C, GRIN3A | PARP10 3694/4885MEN1 4432/4885KMT2A 3249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.